Concepedia

Author

Dae Young Zang

Hallym University Medical CenterORCID

Also Known As

Bo Ram Han, Byung Soo Kim, D Y Zang, D Zang, D. Y. Zang, D. Zang, D.Y. Zang, DAE YOUNG ZANG, Dae Ro Choi, Dae Y. Zang

308

Publications

12.7K

Citations

36

H-Index

66

Concepts

All Affiliations

Hallym University Medical CenterSungkyunkwan UniversityUniversity of UlsanHallym University Sacred Heart HospitalUlsan College
DY

About

Dae Young Zang is an author at Hallym University Medical Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

22

40

1.3K

2

Health Sciences

11

12

482

3

Gastroenterology

10

10

307

4

Cell Biology

2

2

33

5

Diagnostic Sciences

1

1

163

Dae Young Zang

×

87

Publications

3.7K

Citations

33

H-Index

YearCitations

PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer

Yoon‐Koo Kang, Jeong Hwan Yook, Young-Kyu Park,

Journal of Clinical Oncology

2021

332

Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer

Yung‐Jue Bang, Seock‐Ah Im, Keun‐Wook Lee,

Journal of Clinical Oncology

2015

289

A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial☆

S.H. Park, D.H. Lim, Tae Sung Sohn,

Annals of Oncology

2020

272

Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study

S.-E. Lee, Soo Young Choi, Ho Young Song,

Haematologica

2016

163

A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia

Je‐Hwan Lee, Young‐Don Joo, Hawk Kim,

Blood

2011

147

A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer

Jia-Lin Lee, Y-K. Kang, Hye Jin Kang,

British Journal of Cancer

2008

136

Expression of tumor necrosis factor–related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis

Dae Young Zang, Ray G. Goodwin, Michael R. Loken,

Blood

2001

119

Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia

Je‐Hwan Lee, Hawk Kim, Young‐Don Joo,

Journal of Clinical Oncology

2017

81

Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients

Sook Jin Seong, Minkyung Lim, Sang Kyun Sohn,

Annals of Oncology

2012

79

ARTIST 2: Interim results of a phase III trial involving adjuvant chemotherapy and/or chemoradiotherapy after D2-gastrectomy in stage II/III gastric cancer (GC).

Se Hoon Park, Dae Young Zang, Boram Han,

Journal of Clinical Oncology

2019

77

Page 1